Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Merkel Cell Polyomavirus Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT03167164
What this trial is testing

QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy

Who this might be right for
Merkel Cell Carcinoma
ImmunityBio, Inc.
Early research (Phase 1)Study completedNCT00346385
What this trial is testing

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Ovarian CancerMerkel Cell CarcinomaSCLC
ImmunoGen, Inc. 97
Testing effectiveness (Phase 2)Study completedNCT00003549
What this trial is testing

S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer

Who this might be right for
Neuroendocrine Carcinoma of the Skin
SWOG Cancer Research Network 80
Early research (Phase 1)Looking for participantsNCT07006727
What this trial is testing

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaLarge Cell Neuroendocrine Carcinoma of the LungNeuroendocrine Prostate Cancer+8 more
Novartis Pharmaceuticals 116
Testing effectiveness (Phase 2)Study completedNCT01013779
What this trial is testing

Merkel Positron Emission Tomography (PET) Protocol

Who this might be right for
Merkel Cell Carcinoma
Trans Tasman Radiation Oncology Group 43
Early research (Phase 1)Study completedNCT05422781
What this trial is testing

Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC)

Who this might be right for
Merkel Cell Carcinoma
Immunomic Therapeutics, Inc. 6
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Not applicableApproved For MarketingNCT03089658
What this trial is testing

Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)

Who this might be right for
Metastatic Merkel Cell Carcinoma
Merck KGaA, Darmstadt, Germany
Early research (Phase 1)Study completedNCT04160065
What this trial is testing

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaNon-Melanoma Skin Cancers
TuHURA Biosciences, Inc. 23
Not applicableStudy completedNCT03545334
What this trial is testing

Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study

Who this might be right for
Malignant MelanomaMerkel Cell Carcinoma
Insel Gruppe AG, University Hospital Bern 93
Large-scale testing (Phase 3)Looking for participantsNCT06947928
What this trial is testing

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Who this might be right for
Advanced Or Metastatic Merkel Cell Carcinoma
TuHURA Biosciences, Inc. 118
Testing effectiveness (Phase 2)Looking for participantsNCT05583708
What this trial is testing

Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer

Who this might be right for
Merkel Cell Carcinoma
Weill Medical College of Cornell University 18
Testing effectiveness (Phase 2)Ended earlyNCT04725331
What this trial is testing

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Who this might be right for
Metastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more
Transgene 31
Early research (Phase 1)Looking for participantsNCT06940440
What this trial is testing

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)

Who this might be right for
Advanced Or Metastatic Merkel Cell Carcinoma
TuHURA Biosciences, Inc. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Testing effectiveness (Phase 2)Ended earlyNCT04590781
What this trial is testing

Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer

Who this might be right for
Merkel Cell CarcinomaSmall Cell Lung Cancer
Xencor, Inc. 4
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Looking for participantsNCT06223659
What this trial is testing

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

Who this might be right for
Cutaneous MelanomaMerkel Cell CarcinomaSkin Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center 100
Early research (Phase 1)Active Not RecruitingNCT04047251
What this trial is testing

FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma

Who this might be right for
Advanced Solid TumorsMerkel Cell Carcinoma
Fujifilm Pharmaceuticals U.S.A., Inc. 96
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Next Page